The filing is a routine notice of an insider's intent to sell shares acquired via option exercise, likely for tax purposes. The sale amount is small relative to market cap. Monitor for actual completion on Form 4 and for any acceleration of insider selling ahead of upcoming earnings.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 28 $30.61entry
- T+1 · 6d ago −3.01%α −1.23% · $29.69
- T+5 · due 9h ago Pending
- T+5 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Mahboob Vaseem, an officer of Kestra Medical Technologies, filed a Form 144 notice of intent to sell 39,903 shares of common stock, with an approximate market value of $1.22 million, through Merrill Lynch. The shares were acquired via exercise of employee stock options on the same day, and the sale is intended to cover taxes and costs via a broker-assisted cashless exercise. The filing follows a pattern of recent insider selling by Vaseem, who has sold shares on multiple dates over the past three months.
Key Facts
- Officer Mahboob Vaseem filed Form 144 to sell 39,903 shares of Kestra Medical Technologies common stock.
- The proposed sale value is approximately $1.22 million based on the filing date price.
- Shares were acquired on 10/28/2026 via exercise of employee stock options.
- The sale is described as a broker-assisted cashless exercise, likely to cover option exercise costs and taxes.
- Vaseem has sold shares on multiple dates in the prior three months, including 34,809 shares on 10/27/2026.
- The company has a market cap of $1.8 billion; the proposed sale represents about 0.07% of shares outstanding.
- Recent insider activity (30 days) shows 5 sells totaling $3.3 million.
Financial Impact
Proposed sale of 39,903 shares valued at ~$1.22 million, representing ~0.07% of market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not be completed.
- The officer has been a consistent seller over the past three months, which could signal a pattern of monetization.
- No specific catalyst or lock-up expiry date is mentioned in the filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000479 |
| Document: 0001964306-26-000479-index.html | 0001964306-26-000479 |
| Document: 0001964306-26-000479.txt | 0001964306-26-000479 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 today | 144 | $29.82 | awaiting T+20 | awaiting T+20 | $30.99 (+3.91%) |
Oct 29, 2026 5d ago | Insider Cluster | $29.69 | awaiting T+20 | awaiting T+20 | $30.99 (+4.36%) |
Oct 29, 2026 5d ago | 144 | $29.69 | awaiting T+20 | awaiting T+20 | $30.99 (−4.36%) |
Oct 28, 2026 6d ago | 144 | $30.61 | awaiting T+20 | awaiting T+20 | $30.99 (+1.23%) |
Oct 27, 2026 8d ago | 144 | $29.87 | awaiting T+20 | awaiting T+20 | $30.99 (+3.73%) |
Oct 27, 2026 8d ago | 144 | $29.87 | awaiting T+20 | awaiting T+20 | $30.99 (+3.73%) |
Oct 22, 2026 13d ago | Insider Cluster | $28.76 | awaiting T+20 | awaiting T+20 | $30.99 (+7.74%) |
Oct 20, 2026 15d ago | 144 | $27.31 | awaiting T+20 | awaiting T+20 | $30.99 (+13.46%) |
Oct 20, 2026 15d ago | ANALYST-UPGRADE | $28.28 | awaiting T+20 | awaiting T+20 | $30.99 (+9.57%) |
Sep 30, 2026 5w ago | 144 | $27.12 $30.61 | ▲ +12.89% | ▲ +12.19% | $30.99 (+14.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers